691209 news 1784742055 1784742105 <![CDATA[Moonlight Therapeutics Advances Peanut Allergy Trial]]> Georgia Public Broadcasting recently featured Moonlight Therapeutics and its work to advance a new potential treatment for peanut allergies.

Children’s Healthcare of Atlanta is leading the first human clinical trial of the company’s microneedle stamp, which is designed to deliver a precise amount of peanut allergen through the outer layers of the skin. Moonlight Therapeutics President and CEO Samir Patel completed doctoral research at Georgia Tech and co-founded the Atlanta-based biotechnology company to help translate this technology into a potential treatment.

Read the full story from Georgia Public Broadcasting.

]]> 2026-07-13T00:00:00-04:00 Georgia Public Broadcasting recently featured Moonlight Therapeutics and its first human clinical trial for a potential peanut allergy treatment. Co-founded by Georgia Tech alumnus Samir Patel, the Atlanta-based biotechnology company is advancing a microneedle technology designed to deliver treatment through the skin.

]]> 655285 138 139 135 https://www.gpb.org/news/2026/07/13/childrens-healthcare-of-atlanta-leads-multi-site-clinical-trials-for-peanut-allergy 655285 195134